|
CCNF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.5340619319868E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.52479999999877E-05 |
| Normal-vs-Stage2 |
1.120050E-02 |
| Normal-vs-Stage3 |
2.04549999999193E-05 |
| Normal-vs-Stage4 |
9.302600E-03 |
| Stage1-vs-Stage2 |
2.818000E-01 |
| Stage1-vs-Stage3 |
4.023700E-04 |
| Stage1-vs-Stage4 |
2.692300E-02 |
| Stage2-vs-Stage3 |
4.563200E-03 |
| Stage2-vs-Stage4 |
5.219600E-02 |
| Stage3-vs-Stage4 |
7.943600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.72439881554965E-11 |
| Normal-vs-AfricanAmerican |
4.017600E-04 |
| Normal-vs-Asian |
6.502000E-02 |
| Caucasian-vs-AfricanAmerican |
1.218190E-01 |
| Caucasian-vs-Asian |
1.560790E-01 |
| AfricanAmerican-vs-Asian |
1.185030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.61820001421643E-09 |
| Normal-vs-Female |
1.96679999953098E-07 |
| Male-vs-Female |
1.607960E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.416200E-03 |
| Normal-vs-Extreme_Weight |
5.7407999999981E-05 |
| Normal-vs-Obese |
2.26489999999302E-06 |
| Normal-vs-Extreme_Obese |
3.265600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.456570E-01 |
| Normal_Weight-vs-Obese |
7.768800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.939800E-02 |
| Extreme_Weight-vs-Obese |
2.204000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.896200E-01 |
| Obese-vs-Extreme_Obese |
4.258800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.955200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.01380004391416E-09 |
| Normal-vs-Age(61-80Yrs) |
2.2878000000004E-06 |
| Normal-vs-Age(81-100Yrs) |
3.617200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.449900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.444900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.164100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.817800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.895900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.090300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.07390000003704E-07 |
| Normal-VS-Type2 PRCC |
7.77150000000892E-05 |
| Normal-VS-KIRP CIMP |
1.59970999999981E-05 |
| Normal-VS-Unclassified PRCC |
6.08329999999269E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.533000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.40989999999996E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.131600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.63824509513688E-12 |
| Type2 PRCC-VS-Unclassified PRCC |
1.645970E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.76509995508667E-09 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.226100E-04 |
| Normal-vs-N1 |
5.84210000043051E-07 |
| Normal-vs-N2 |
1.802250E-01 |
| N0-vs-N1 |
5.9264999999975E-05 |
| N0-vs-N2 |
5.837900E-02 |
| N1-vs-N2 |
4.906000E-01 |
|
|
